Michel Dubois
Director/Board Member at GENEURO SA
Michel Dubois active positions
Companies | Position | Start | End |
---|---|---|---|
GENEURO SA | Director/Board Member | 2008-07-15 | - |
Independent Dir/Board Member | 2008-07-15 | - | |
GeNeuro SA
GeNeuro SA BiotechnologyHealth Technology Part of GeNeuro SA (Switzerland), the French company develops and manufactures therapeutic products. The company is based in Lyon, France. | Director/Board Member | 2010-07-25 | - |
Centre Hospitalier Saint Joseph - Saint Luc | Director/Board Member | - | - |
Career history of Michel Dubois
Former positions of Michel Dubois
Companies | Position | Start | End |
---|---|---|---|
TRANSGENE | Chairman | 2005-12-31 | 2010-06-16 |
ANO Consultants & Participations SARL | Corporate Officer/Principal | 2005-12-31 | 2009-12-31 |
Biotek Partenaires SAS
Biotek Partenaires SAS Investment ManagersFinance Biotek Partenaires SAS (Biotek Partenaires) is a venture capital firm, a subsidiary of Banque Saint Olive. The firm is founded in 1998 by Saint-Olive. The firm headquartered in Lyon, France. | Chairman | - | 2009-04-26 |
Chief Investment Officer | - | 2009-04-13 | |
Director of Investments | - | 2009-04-26 | |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Chief Executive Officer | - | - |
GeNeuro Innovation SAS
GeNeuro Innovation SAS Miscellaneous Commercial ServicesCommercial Services Part of GeNeuro SA (Switzerland), GeNeuro Innovation SAS is a French company that specializes in developing therapeutic products for the treatment of neurological disorders such as multiple sclerosis, schizophrenia, and autoimmune disorders like diabetes. The company focuses on developing new therapeutics that address nervous system pathologies involving human endogenous retroviruses (HERVs). | Chairman | 2007-12-31 | - |
TSGH SAS
TSGH SAS Financial ConglomeratesFinance TSGH SAS operates as an investment holding company. The company is headquartered in Lyon, France. | Chairman | 2010-07-25 | - |
░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Training of Michel Dubois
Sciences Po | Undergraduate Degree |
Université Paris 1 Panthéon-Sorbonne | Graduate Degree |
Statistics
International
France | 12 |
Switzerland | 2 |
Operational
Chairman | 4 |
Director/Board Member | 4 |
Independent Dir/Board Member | 2 |
Sectoral
Health Technology | 6 |
Finance | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
TRANSGENE | Health Technology |
GENEURO SA | Health Technology |
Private companies | 8 |
---|---|
Biotek Partenaires SAS
Biotek Partenaires SAS Investment ManagersFinance Biotek Partenaires SAS (Biotek Partenaires) is a venture capital firm, a subsidiary of Banque Saint Olive. The firm is founded in 1998 by Saint-Olive. The firm headquartered in Lyon, France. | Finance |
Stallergenes SA
Stallergenes SA Pharmaceuticals: MajorHealth Technology Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France. | Health Technology |
GeNeuro SA
GeNeuro SA BiotechnologyHealth Technology Part of GeNeuro SA (Switzerland), the French company develops and manufactures therapeutic products. The company is based in Lyon, France. | Health Technology |
TSGH SAS
TSGH SAS Financial ConglomeratesFinance TSGH SAS operates as an investment holding company. The company is headquartered in Lyon, France. | Finance |
ANO Consultants & Participations SARL | |
GeNeuro Innovation SAS
GeNeuro Innovation SAS Miscellaneous Commercial ServicesCommercial Services Part of GeNeuro SA (Switzerland), GeNeuro Innovation SAS is a French company that specializes in developing therapeutic products for the treatment of neurological disorders such as multiple sclerosis, schizophrenia, and autoimmune disorders like diabetes. The company focuses on developing new therapeutics that address nervous system pathologies involving human endogenous retroviruses (HERVs). | Commercial Services |
Centre Hospitalier Saint Joseph - Saint Luc | |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Health Technology |
- Stock Market
- Insiders
- Michel Dubois
- Experience